Correlations between in-vitro and clinical drug response to CFTR modulators

被引：0
|
作者：
Ratjen, Felix [1 ]
Stanojevic, Sanja [2 ]
Gunawardena, Tarini [1 ]
Moraes, Theo [1 ]
Gonska, Tanja [1 ]
Eckford, Paul [1 ]
Bear, Christine [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA3375
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] IN-VITRO REPLICATION OF CLINICAL TOOTHBRUSHING
    ANDERSON, JC
    DOUGLAS, WH
    PINTADO, MR
    DELONG, R
    JOURNAL OF DENTAL RESEARCH, 1994, 73 : 164 - 164
  • [42] CLINDAMYCIN - IN-VITRO AND CLINICAL STUDIES
    MORIN, G
    PROULX, P
    MASSICOT.C
    SIMARD, D
    UNION MEDICALE DU CANADA, 1971, 100 (09): : 1809 - &
  • [43] RELATIONSHIP BETWEEN EFFECT OF ACTIVATED CHARCOAL ON DRUG ABSORPTION IN MAN AND ITS DRUG ADSORPTION CHARACTERISTICS IN-VITRO
    TSUCHIYA, T
    LEVY, G
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (04) : 586 - &
  • [44] Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators
    Terlizzi, Vito
    Pesce, Emanuela
    Capurro, Valeria
    Tomati, Valeria
    Lena, Mariateresa
    Pastorino, Cristina
    Bocciardi, Renata
    Zara, Federico
    Centrone, Claudia
    Taccetti, Giovanni
    Castellani, Carlo
    Pedemonte, Nicoletta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [45] Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis
    Jia, Shijing
    Wang, Yizhuo
    Ross, Melissa H.
    Zuckerman, Jonathan B.
    Murray, Susan
    Han, MeiLan K.
    Cahalan, Shannon E.
    Lenhan, Blair E.
    Best, Ryan N.
    Taylor-Cousar, Jennifer
    Simon, Richard
    Fitzgerald, Linda J.
    Troost, Jonathan
    Sood, Suman L.
    Gifford, Alex H.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (05) : 878 - 884
  • [46] CORRELATIONS BETWEEN THERAPEUTIC RESPONSE OF LEUKEMIAS AND INVITRO DRUG-SENSITIVITY ASSAY
    BOSANQUET, AG
    LANCET, 1991, 337 (8743): : 711 - 714
  • [47] ROLES FOR IN-VITRO MYELOTOXICITY TESTS IN PRECLINICAL DRUG DEVELOPMENT AND CLINICAL-TRIAL PLANNING
    PARCHMENT, RE
    HUANG, M
    ERICKSONMILLER, CL
    TOXICOLOGIC PATHOLOGY, 1993, 21 (02) : 241 - 250
  • [48] NEUROPEPTIDES ARE POTENT MODULATORS OF HUMAN IN-VITRO IMMUNOGLOBULIN-E SYNTHESIS
    AEBISCHER, I
    STAMPFLI, MR
    ZURCHER, A
    MIESCHER, S
    URWYLER, A
    FREY, B
    LUGER, T
    WHITE, RR
    STADLER, BM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) : 1908 - 1913
  • [49] Rapid cystic fibrosis lung-function decline and in-vitro CFTR modulation
    Gecili, Emrah
    Su, Weiji
    Brokamp, Cole
    Andrinopoulou, Eleni-Rosalina
    LaRosa, Francis J., III
    Pestian, Teresa
    Clancy, John P.
    Solomon, George M.
    Brewington, John J.
    Szczesniak, Rhonda D.
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (05) : E69 - E71
  • [50] Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators
    Han, Sangwoo T.
    Rab, Andras
    Pellicore, Matthew J.
    Davis, Emily F.
    McCague, Allison F.
    Evans, Taylor A.
    Joynt, Anya T.
    Lu, Zhongzhou
    Cai, Zhiwei
    Raraigh, Karen S.
    Hong, Jeong S.
    Sheppard, David N.
    Sorscher, Eric J.
    Cutting, Garry R.
    JCI INSIGHT, 2018, 3 (14):
12345